QQ客服 官方微博 反馈留言

	Repositioning Dopamine D2 Receptor Agonist Bromocriptine to Enhance Docetaxel Chemotherapy and Treat Bone Metastatic Prostate Cancer
	Yang, Yang; Mamouni, Kenza; Li, Xin; Chen, Yanhua; Kavuri, Sravan; Du, Yuhong; Fu, Haian; Kucuk, Omer; Wu, Daqing
刊名	MOLECULAR CANCER THERAPEUTICS
	2018
卷号	Vol.17 No.9页码:1859-1870
ISSN号	1535-7163
URL标识	查看原文
公开日期	[db:dc_date_available]
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/5466287
专题	湖南大学
作者单位	1.Huazhong Univ Sci & Technol, Union Hosp, Dept Otorhinolaryngol, Tongji Med Coll, Wuhan 430022, Hubei, Peoples R China 2.Georgia Canc Ctr, Mol Oncol & Biomarkers Program, Augusta, GA USA 3.Augusta Univ, Dept Biochem & Mol Biol, Med Coll Georgia, Augusta, GA 30912 USA 4.Huazhong Univ Sci & Technol, Union Hosp, Dept Hand Surg, Tongji Med Coll, Wuhan 430022, Hubei, Peoples R China 5.Augusta Univ, Dept Pathol, Med Coll Georgia, Augusta, GA 30912 USA 6.Emory Univ, Sch Med, Dept Pharmacol, Atlanta, GA 30322 USA 7.Emory Univ, Emory Chem Biol Discovery Ctr, Sch Med, Atlanta, GA USA 8.Emory Univ, Sch Med, Dept Hematol & Med Oncol, Winship Canc Inst, Atlanta, GA USA 9.MetCure Therapeut LLC, Atlanta, GA USA
推荐引用方式 GB/T 7714	Yang, Yang,Mamouni, Kenza,Li, Xin,et al. Repositioning Dopamine D2 Receptor Agonist Bromocriptine to Enhance Docetaxel Chemotherapy and Treat Bone Metastatic Prostate Cancer[J]. MOLECULAR CANCER THERAPEUTICS,2018,Vol.17 No.9:1859-1870.
APA	Yang, Yang.,Mamouni, Kenza.,Li, Xin.,Chen, Yanhua.,Kavuri, Sravan.,...&Wu, Daqing.(2018).Repositioning Dopamine D2 Receptor Agonist Bromocriptine to Enhance Docetaxel Chemotherapy and Treat Bone Metastatic Prostate Cancer.MOLECULAR CANCER THERAPEUTICS,Vol.17 No.9,1859-1870.
MLA	Yang, Yang,et al."Repositioning Dopamine D2 Receptor Agonist Bromocriptine to Enhance Docetaxel Chemotherapy and Treat Bone Metastatic Prostate Cancer".MOLECULAR CANCER THERAPEUTICS Vol.17 No.9(2018):1859-1870.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。